Baran Ayhan is currently a Molecule Lead in Portfolio and Pipeline Planning at Roche, where they guide cross-functional teams in addressing complex business challenges. Previously, Ayhan held multiple leadership roles at Roche from 2015 to 2023, including Disease Area Lead for Neurodegeneration and Cardiovascular and Metabolism, as well as Head of Pharma Capital Management. Ayhan's career includes experience as a Senior Consultant at Arthur Andersen and as a Senior Associate in Private Equity at Adveq. They began their professional journey as a Financial Analyst at Adecco in 2005. Ayhan earned a BA from Bogazici University and an MBA from Babson College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices